Literature DB >> 15781931

A population based study of the impact of corticosteroid therapy and delayed diagnosis on the outcome of childhood pneumococcal meningitis.

P B McIntyre1, C R Macintyre, R Gilmour, H Wang.   

Abstract

BACKGROUND: Despite an extensive literature, the impact of both adjunctive steroid therapy and delayed diagnosis on the outcome of childhood pneumococcal meningitis is controversial. AIM: To determine the independent contribution of corticosteroid therapy and delayed diagnosis on the outcome of childhood pneumococcal meningitis in a representative population with good access to medical services.
METHODS: Data were obtained from laboratories and hospital records to assemble a population register in Sydney, Australia, 1994-99. Follow up questionnaires were completed by attending physicians.
RESULTS: A total of 122 cases of pneumococcal meningitis aged 0-14 years were identified. Almost 50% of 120 children with available records either died (n = 15) or had permanent neurological impairment (n = 39). Early use (before or with parenteral antibiotics) of corticosteroids protected against death or severe morbidity (adjusted OR 0.21, 95% CI 0.05 to 0.77). Delayed diagnosis was associated with increased morbidity in survivors (OR 3.4, 95% CI 1.03 to 11.4) but not with increased mortality.
CONCLUSION: In a population with good access to health care and after adjusting for other known prognostic variables, early recognition of pneumococcal meningitis and treatment with adjunctive dexamethasone significantly improves outcomes. These data add to those from randomised controlled trials. Implementation requires development of protocols and guidelines for use in emergency departments.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15781931      PMCID: PMC1720332          DOI: 10.1136/adc.2003.037523

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  21 in total

1.  The emergence of resistant pneumococcal meningitis--implications for empiric therapy.

Authors:  P McMaster; P McIntyre; R Gilmour; L Gilbert; A Kakakios; C Mellis
Journal:  Arch Dis Child       Date:  2002-09       Impact factor: 3.791

2.  Bacterial meningitis in childhood at the Children's Hospital of Pittsburgh: 1988-1998.

Authors:  H B Neuman; E R Wald
Journal:  Clin Pediatr (Phila)       Date:  2001-11       Impact factor: 1.168

3.  Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988.

Authors:  P B McIntyre; C S Berkey; S M King; U B Schaad; T Kilpi; G Y Kanra; C M Perez
Journal:  JAMA       Date:  1997-09-17       Impact factor: 56.272

4.  Twelve year outcomes following bacterial meningitis: further evidence for persisting effects.

Authors:  K Grimwood; P Anderson; V Anderson; L Tan; T Nolan
Journal:  Arch Dis Child       Date:  2000-08       Impact factor: 3.791

5.  Pneumococcal meningitis in children: relationship of antibiotic resistance to clinical characteristics and outcomes.

Authors:  S C Buckingham; J A McCullers; J Luján-Zilbermann; K M Knapp; K L Orman; B K English
Journal:  Pediatr Infect Dis J       Date:  2001-09       Impact factor: 2.129

6.  Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials.

Authors:  M H Lebel; B J Freij; G A Syrogiannopoulos; D F Chrane; M J Hoyt; S M Stewart; B D Kennard; K D Olsen; G H McCracken
Journal:  N Engl J Med       Date:  1988-10-13       Impact factor: 91.245

7.  Incidence of invasive pneumococcal disease in Sydney children, 1991-96.

Authors:  J L Liddle; P B McIntyre; C W Davis
Journal:  J Paediatr Child Health       Date:  1999-02       Impact factor: 1.954

8.  Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use.

Authors:  M Arditi; E O Mason; J S Bradley; T Q Tan; W J Barson; G E Schutze; E R Wald; L B Givner; K S Kim; R Yogev; S L Kaplan
Journal:  Pediatrics       Date:  1998-11       Impact factor: 7.124

9.  Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial.

Authors:  E M Molyneux; A L Walsh; H Forsyth; M Tembo; J Mwenechanya; K Kayira; L Bwanaisa; A Njobvu; S Rogerson; G Malenga
Journal:  Lancet       Date:  2002-07-20       Impact factor: 79.321

10.  Length of prediagnostic history related to the course and sequelae of childhood bacterial meningitis.

Authors:  T Kilpi; M Anttila; M J Kallio; H Peltola
Journal:  Pediatr Infect Dis J       Date:  1993-03       Impact factor: 2.129

View more
  18 in total

Review 1.  Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis.

Authors:  Matthijs C Brouwer; Allan R Tunkel; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

2.  Pneumococcal meningitis: clinical outcomes in a pre-vaccine era at a Dublin paediatric hospital, 1999-2007.

Authors:  J M Lucey; P Gavin; M Cafferkey; K M Butler
Journal:  Ir J Med Sci       Date:  2010-11-12       Impact factor: 1.568

3.  Bacterial pore-forming cytolysins induce neuronal damage in a rat model of neonatal meningitis.

Authors:  Anja Reiss; Johann S Braun; Katja Jäger; Dorette Freyer; Gregor Laube; Christoph Bührer; Ursula Felderhoff-Müser; Christine Stadelmann; Victor Nizet; Joerg R Weber
Journal:  J Infect Dis       Date:  2010-12-24       Impact factor: 5.226

4.  Systems for Paediatric Sepsis: A Global Survey.

Authors:  K T Kang; H K Chandler; V Espinosa; N Kissoon
Journal:  West Indian Med J       Date:  2014-09-03       Impact factor: 0.171

Review 5.  Management of the Febrile Young Infant: Update for the 21st Century.

Authors:  Christopher Woll; Mark I Neuman; Paul L Aronson
Journal:  Pediatr Emerg Care       Date:  2017-11       Impact factor: 1.454

6.  Burden of paediatric invasive pneumococcal disease in Europe, 2005.

Authors:  E D G McIntosh; B Fritzell; M A Fletcher
Journal:  Epidemiol Infect       Date:  2006-09-07       Impact factor: 2.451

7.  Early symptomatic and late seizures in Kosovar children with bacterial meningitis.

Authors:  Sadie A Namani; Ernest Kuchar; Remzie Koci; Murat Mehmeti; Kreshnike Dedushi
Journal:  Childs Nerv Syst       Date:  2011-05-20       Impact factor: 1.475

8.  Streptococcus pneumoniae meningitis in Alberta pre- and postintroduction of the 7-valent pneumococcal conjugate vaccine.

Authors:  Jennie Johnstone; Gregory J Tyrrell; Thomas J Marrie; Sipi Garg; James D Kellner
Journal:  Can J Infect Dis Med Microbiol       Date:  2011       Impact factor: 2.471

9.  Pneumococcal meningitis in the era of pneumococcal conjugate vaccine implementation.

Authors:  E Bingen; C Levy; E Varon; F de La Rocque; M Boucherat; P d'Athis; Y Aujard; R Cohen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-11-30       Impact factor: 3.267

10.  Guidelines for the management of suspected and confirmed bacterial meningitis in Canadian children older than one month of age.

Authors:  Nicole Le Saux
Journal:  Paediatr Child Health       Date:  2014-03       Impact factor: 2.253

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.